Edition:
United States

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

5.11USD
11 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.11
Open
$5.09
Day's High
$5.21
Day's Low
$4.94
Volume
41,719
Avg. Vol
106,985
52-wk High
$9.49
52-wk Low
$1.88

Chart for

About

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease and cancer. The Company's drug candidates are based on its method of targeting galectin proteins, which are mediators of biologic and pathologic functions. It uses naturally... (more)

Overall

Beta: 2.59
Market Cap(Mil.): $85.53
Shares Outstanding(Mil.): 35.05
Dividend: --
Yield (%): --

Financials

  GALT.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -0.62 -- --
ROI: -181.73 0.29 15.02
ROE: -1,032.02 0.94 16.60

Earnings vs. Estimates